Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsDIANE Publishing, 1997 - 170 pages Presents the National Cholesterol Education Program's updated recommendations for cholesterol management with examination of available evidence on coronary heart disease (CHD) and high blood cholesterol. Topics of discussion include: patients with established CHD and others at high risk; cholesterol lowering in women, the elderly, and young adults; physical activity and weight loss as components of dietary therapy; drug therapy; cholesterol lowering and total mortality; and cost-effectiveness of cholesterol lowering. Includes tables and dietary recommendations with sample menus. |
From inside the book
Results 1-5 of 18
Page xix
... medication and the need for long - term commitment . Consultation with a lipid specialist generally is needed only for patients with unusually severe , complex , or refractory lipid disorders , and the primary care provider can oversee ...
... medication and the need for long - term commitment . Consultation with a lipid specialist generally is needed only for patients with unusually severe , complex , or refractory lipid disorders , and the primary care provider can oversee ...
Page 11
... medication ) • Low HDL - cholesterol ( < 35 mg / dL * ) • Diabetes mellitus Negative Risk Factor ** • High HDL - cholesterol ( ≥60 mg / dL ) High risk , defined as a net of two or more CHD risk factors , leads to more vigorous ...
... medication ) • Low HDL - cholesterol ( < 35 mg / dL * ) • Diabetes mellitus Negative Risk Factor ** • High HDL - cholesterol ( ≥60 mg / dL ) High risk , defined as a net of two or more CHD risk factors , leads to more vigorous ...
Page 14
... medications , and chronic coronary care . In addition , income is lost . due to chronic illness and disability . The total ... medication.256 For patients with CHD or middle - age and older adults with multiple risk factors , use of ...
... medications , and chronic coronary care . In addition , income is lost . due to chronic illness and disability . The total ... medication.256 For patients with CHD or middle - age and older adults with multiple risk factors , use of ...
Page 5
... medications therefore should be taken at least 1 hour before or 4 hours after the sequestrant . The sequestrants have ... medication with nicotinic acid should be discouraged . 85 Nicotinic acid appears to alter lipid levels by reducing ...
... medications therefore should be taken at least 1 hour before or 4 hours after the sequestrant . The sequestrants have ... medication with nicotinic acid should be discouraged . 85 Nicotinic acid appears to alter lipid levels by reducing ...
Page 9
... medications.470, 73,474 However , the spontaneous reporting system of the FDA contains a few reports of rhabdomyolysis occurring in patients on monotherapy . Severe myopathy is more frequent when statins , especially at higher doses ...
... medications.470, 73,474 However , the spontaneous reporting system of the FDA contains a few reports of rhabdomyolysis occurring in patients on monotherapy . Severe myopathy is more frequent when statins , especially at higher doses ...
Common terms and phrases
adherence adults apolipoprotein atherosclerosis atherosclerotic disease bile acid sequestrants blood pressure calories cardiovascular CHD risk factors Cheese cholesterol lowering cholestyramine Clin clinical trials combined hyperlipidemia coronary heart disease cost-effectiveness diabetes mellitus dietary therapy dietitian dose drug therapy dyslipidemia elderly Engl established CHD estrogen replacement familial hypercholesterolemia fatty acids fibric acid gemfibrozil goal Grundy SM high blood cholesterol high cholesterol levels high-risk hypertension hypertriglyceridemia intake JAMA kcals LDL-cholesterol levels lipid lipids and lipoproteins long-term lovastatin low density lipoprotein low HDL-cholesterol low sodium low-fat lower LDL-cholesterol margarine margarine 1/2 tsp meat Metabolism mg/dL myocardial infarction niacin nicotinic acid obesity percent physical activity primary prevention probucol protein recommended reduce CHD risk for CHD saturated fat seasoned with margarine secondary prevention serum cholesterol side effects statins Step II Diet total cholesterol levels Total Fat total mortality triglyceride levels triglycerides Vegetable Oil VLDL weight reduction women
Popular passages
Page 11 - Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.
Page 4 - Frick MH, Elo O, Haapa K, et al: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia; safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Page 13 - The Lipid Research Clinics population studies data book. Vol. I. The prevalence study: aggregate distributions of lipids, lipoproteins and selected variables in 11 North American populations.
Page i - National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II).
Page 14 - Friedewald WT. Levy RI. Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
Page 15 - Nationwide food consumption survey: continuing survey of food intakes by individuals, women 1950 years and their children 1-5 years, 1 day.
Page 5 - Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.
Page 15 - Hegsted DM. McGandy RB. Myers ML. Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man.
Page 15 - Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B. 1981. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J Clin Invest 67:493—502.
Page 16 - Mattson FH. Grundy SM. Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.